Advertisement

Molecular Medicine

, Volume 18, Issue 2, pp 178–185 | Cite as

β-Amyloid Carrying the Dutch Mutation Has Diverse Effects on Calpain-Mediated Toxicity in Hippocampal Neurons

  • Alexandra M. Nicholson
  • Lindsey A. Wold
  • Dominic M. Walsh
  • Adriana Ferreira
Research Article

Abstract

Hereditary cerebral hemorrhage with amyloidosis-Dutch type is a disorder associated with a missense mutation (E693Q) in the β-amyloid (Aβ)-coding region of the amyloid precursor protein (APP). This familial disease is characterized by cognitive deficits secondary to intracerebral hemorrhage and, in some cases, progressive Alzheimer’s disease (AD)-like dementia. Although this mutation was the first ever reported in the human APP gene, little is known about the molecular mechanisms underlying the direct toxic effects of this mutated Aβ on central neurons. In the present study, we assessed the role of calpain-mediated toxicity in such effects using an AD primary culture model system. Our results showed that Dutch mutant Aβ (E22Q) induced calpain-mediated cleavage of dynamin 1 and a significant decrease in synaptic contacts in mature hippocampal cultures. These synaptic deficits were similar to those induced by wild-type (WT) Aβ. In contrast, calpain-mediated tau cleavage leading to the generation of a 17-kDa neurotoxic fragment, as well as neuronal death, were significantly reduced in E22Q Aβ-treated neurons when compared with WT Aβ-treated ones. This complex regulation of the calpain-mediated toxicity pathway by E22Q Aβ could have some bearing in the pathobiology of this familial AD form.

Notes

Acknowledgments

We thank Sara Kleinschmidt and Jessica Bernstein for their contributions to the early stages of this work. This study was supported by grants NIH/NS39080 to A Ferreira and Wellcome Trust grant 067660 and NIH AG027443 to DM Walsh.

References

  1. 1.
    Saito K, Elce JS, Hamos JE, Nixon RA. (1993) Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proc. Natl. Acad. Sci. U. S. A. 90:2628–32.CrossRefGoogle Scholar
  2. 2.
    Tsuji T, Shimohama S, Kimura J, Shimizu K. (1998) m-Calpain (calcium-activated neutral proteinase) in Alzheimer’s disease brains. Neurosci. Lett. 248:109–12.CrossRefGoogle Scholar
  3. 3.
    Veerana J, et al. (2004) Calpain mediates calcium-induced activation of the erk1,2 MAPK pathway and cytoskeletal phosphorylation in neurons: relevance to Alzheimer’s disease. Am. J. Pathol. 165:795–805.CrossRefGoogle Scholar
  4. 4.
    Kelly BL, Vassar R, Ferreira A. (2005) Beta-amyloid-induced dynamin 1 depletion in hippocampal neurons: a potential mechanism for early cognitive decline in Alzheimer disease. J. Biol. Chem. 280:31746–53.CrossRefGoogle Scholar
  5. 5.
    Kelly BL, Ferreira A. (2006) Beta-amyloid-induced dynamin 1 degradation is mediated by NMDA receptors in hippocampal neurons. J. Biol. Chem. 281:28079–89.CrossRefGoogle Scholar
  6. 6.
    Nicholson A, Ferreira A. (2009) Increased membrane cholesterol might render mature hippocampal neurons more susceptible to beta-amyloid-induced calpain activation and tau toxicity. J. Neurosci. 29:4640–51.CrossRefGoogle Scholar
  7. 7.
    Damke H, Baba T, Warnock DE, Schmid SL (1994) Induction of mutant dynamin specifically blocks endocytic coated vesicle formation. J. Cell. Biol. 127:915–34.CrossRefGoogle Scholar
  8. 8.
    Clark SG, Shurland DL, Meyerowitz EM, Bargmann CI, van der Bliek AM. (1997) A dynamin GTPase mutation causes a rapid and reversible temperature-inducible locomotion defect in C. elegans. Proc. Natl. Acad. Sci. U. S. A. 94:10438–43.CrossRefGoogle Scholar
  9. 9.
    Kelly BL, Ferreira A. (2007) Beta-amyloid disrupted synaptic vesicle endocytosis in cultured hippocampal neurons. Neuroscience. 146:60–70.CrossRefGoogle Scholar
  10. 10.
    Park SY, Ferreira A. (2005) The generation of a 17 kDa neurotoxic fragment: an alternative mechanism by which tau mediates beta-amyloid-induced neurodegeneration. J. Neurosci. 25:5365–75.CrossRefGoogle Scholar
  11. 11.
    Park SY, Tournell C, Sinjoanu RC, Ferreira A. (2007) Caspase-3- and calpain-mediated tau cleavage are differentially prevented by estrogen and testosterone in beta-amyloid-treated hippocampal neurons. Neuroscience. 144:119–27.CrossRefGoogle Scholar
  12. 12.
    Sinjoanu RC, et al. (2008) The novel calpain inhibitor A-705253 potently inhibits oligomeric beta-amyloid-induced dynamin 1 and tau cleavage in hippocampal neurons. Neurochem. Intl. 53:79–88.CrossRefGoogle Scholar
  13. 13.
    Levy E, et al. (1990) Mutation of the Alzheimer’s disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science. 248:1124–6.CrossRefGoogle Scholar
  14. 14.
    Mirravalle L, et al. (2000) Substitutions at codon 22 of Alzheimer’s abeta peptide induce diverse conformational changes and apoptotic effects in human cerebral endothelial cells. J. Biol. Chem. 275:27110–6.Google Scholar
  15. 15.
    Natte R, et al. (2001) Dementia in hereditary cerebral hemorrhage with amyloidosis-Dutch type is associated with cerebral amyloid angiopathy but is independent of plaques and neurofibrillary tangles. Ann. Neurol. 50:765–72.CrossRefGoogle Scholar
  16. 16.
    Murakami K, et al. (2003) Neurotoxicity and physicochemical properties of Abeta mutant peptides from cerebral amyloid angiopathy. J. Biol. Chem. 278:46179–87.CrossRefGoogle Scholar
  17. 17.
    Herzig MC, et al. (2004) Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis. Nat. Neurosci. 7:954–60.CrossRefGoogle Scholar
  18. 18.
    Davis J, Cribbs DH, Cotman CW, Van Nostrand WE. (1999) Pathogenic amyloid beta protein induces apoptosis in cultured human cerebrovascular smooth muscle cells. Amyloid. 6:157–64.CrossRefGoogle Scholar
  19. 19.
    Melchor JP, McVoy L, Van Nostrand WE. (2000) Charge alterations of E22 enhance the pathogenic properties of the amyloid-beta protein. J. Neurochem. 74:2209–12.CrossRefGoogle Scholar
  20. 20.
    Dahlgren KN, et al. (2002) Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. J. Biol. Chem. 277:32046–53.CrossRefGoogle Scholar
  21. 21.
    Goslin K, Asmussen H, Banker G. (1998) Rat hippocampal neurons in low-density culture. In: Culturing Nerve Cells. 2nd ed. Banker G, Goslin K (eds.). Cambridge, MA: MIT Press. pp. 339–57.Google Scholar
  22. 22.
    Bottenstein JE, Sato GH. (1979) Growth of a rat neuroblastoma cell line in serum-free supplemented medium. Proc. Natl. Acad. Sci. U. S. A. 76:514–7.CrossRefGoogle Scholar
  23. 23.
    Rapoport M, Ferreira A. (2000) PD98059 prevents neurite degeneration induced by fibrillar beta amyloid in mature hippocampal neurons. J. Neurochem. 74:125–33.CrossRefGoogle Scholar
  24. 24.
    Black L, Berenbaum MC. (1964) Factors affecting the dye exclusion test for cell viability. Exp. Cell. Res. 35:9–13.CrossRefGoogle Scholar
  25. 25.
    Laemmli UK. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:680–5.CrossRefGoogle Scholar
  26. 26.
    Towbin H, Staehelin T, Gordon J. (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U. S. A. 76:4350–4.CrossRefGoogle Scholar
  27. 27.
    Ferreira A, Lu Q, Orecchio L, Kosik KS. (1997) Selective phosphorylation of adult tau isoforms in mature hippocampal neurons exposed to fibrillar A beta. Mol. Cell. Neurosci. 9:220–34.CrossRefGoogle Scholar
  28. 28.
    Yakunin AF, Hallenbeck PC. (1998) A luminol/iodophenol chemiluminescent detection system for Western immunoblots. Anal. Biochem. 258:146–9.CrossRefGoogle Scholar
  29. 29.
    Ferreira A, Busciglio J, Caceres A. (1989) Microtubule formation and neurite growth in cerebellar macroneurons which develop in vitro: evidence for the involvement of the microtubule-associated proteins, MAP-1a, HMW-MAP2 and Tau. Brain Res. Dev. Brain Res. 49:215–28.CrossRefGoogle Scholar
  30. 30.
    Rapoport M, Dawson HN, Binder LI, Vitek M, Ferreira A. (2002) Tau is essential for beta-amyloid induced neurotoxicity. Proc. Natl. Acad. Sci. U. S. A. 99:6364–9.CrossRefGoogle Scholar
  31. 31.
    Fletcher TL, Cameron P, De Camilli P, Banker G. (1991) The distribution of synapsin I and synaptophysin in hippocampal neurons developing in culture. J. Neurosci. 11:1617–26.CrossRefGoogle Scholar
  32. 32.
    Czogalla A, Sikorski AF. (2005) Spectrin and calpain: a ‘target’ and a ‘sniper’ in the pathology of neuronal cells. Cell Mol. Life Sci. 62:1913–24.CrossRefGoogle Scholar
  33. 33.
    Koenig JH, Ikeda K. (1989) Disappearance and reformation of synaptic vesicle membrane upon transmitter release observed under reversible blockage of membrane retrieval. J. Neurosci. 9:3844–60.CrossRefGoogle Scholar
  34. 34.
    Kosaka T, Ikeda K. (1983) Possible temperature-dependent blockage of synaptic vesicle recycling induced by a single gene mutation in Drosophila. J. Neurobiol. 14:207–25.CrossRefGoogle Scholar
  35. 35.
    van der Bliek AM, Meyerowitz EM. (1991) Dynamin-like protein encoded by the Drosophila shibire gene associated with vesicular traffic. Nature. 351:411–4.CrossRefGoogle Scholar
  36. 36.
    Maat-Schieman ML, van Duinen SG, Bornebroek M, Haan J, Roos RA. (1996) Hereditary cerebral hemorrhage with amyloidosis-Dutch type (HCHWA-D): II. A review of histopathological aspects. Brain Pathol. 6:115–20.CrossRefGoogle Scholar
  37. 37.
    Demeester N, et al. (2001) Comparison of the aggregation properties, secondary structure and apoptotic effects of wild-type, Flemish and Dutch N-terminally truncated amyloid beta peptides. Eur. J. Neurosci. 13:2015–24.CrossRefGoogle Scholar
  38. 38.
    Baumketner A, Krone MG, Shea JE. (2008) Role of the familial Dutch mutation EE22Q in the folding and aggregation of the 15–28 fragment of the Alzheimer amyloid-beta protein. Proc. Natl. Acad. Sci. U. S. A. 105:6027–32.CrossRefGoogle Scholar
  39. 39.
    Kumar-Sing S, et al. (2002) In vitro studies of Flemish, Dutch, and Wild-type-amyloid provide evidence for two staged neurotoxicity. Neurobiol. Dis. 11:330–40.CrossRefGoogle Scholar
  40. 40.
    Watterndorff AR, Frangione B, Luyendijk W, Bots GT. (1995) Hereditary cerebral hemorrhage with amyloidosis, Dutch type (HCHWA-D): clinicopathological studies. J. Neurol. Neurosurg. Psych. 58:699–705.CrossRefGoogle Scholar
  41. 41.
    Maat-Schieman ML, Radder CM, van Duinen SG, Haan J, Roos RA. (1994) Hereditary cerebral hemorrhage with amyloidosis (Dutch): a model for congophilic plaque formation without neurofibrillary pathology. Acta. Neuroph. 88:371–8.CrossRefGoogle Scholar
  42. 42.
    Bornebroek M, et al. (1996) Hereditary cerebral hemorrhage with amyloidosis-Dutch type: better correlation of cognitive deterioration with advancing age than with number of focal lesions or white matter hyperintensities. Alz. Dis. Ass. Dis. 10:224–31.CrossRefGoogle Scholar
  43. 43.
    Goll DE, Thompson VF, Li H, Wei W, Cong J. (2003) The calpain system. Physiol. Rev. 83:731–801.CrossRefGoogle Scholar
  44. 44.
    Busciglio J, Lorenzo A, Yeh J, Yankner BA. (1995) Beta-amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron. 14:879–88.CrossRefGoogle Scholar

Copyright information

© The Author(s) 2012

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, and provide a link to the Creative Commons license. You do not have permission under this license to share adapted material derived from this article or parts of it.

The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

To view a copy of this license, visit (https://doi.org/creativecommons.org/licenses/by-nc-nd/4.0/)

Authors and Affiliations

  • Alexandra M. Nicholson
    • 1
  • Lindsey A. Wold
    • 1
  • Dominic M. Walsh
    • 2
  • Adriana Ferreira
    • 1
  1. 1.Department of Cell and Molecular Biology, Feinberg School of MedicineNorthwestern University, Ward Building Room 8-140ChicagoUSA
  2. 2.Laboratory for Neurodegenerative Research, Conway InstituteUniversity College of DublinDublinRepublic of Ireland

Personalised recommendations